Garcia Peter S

Avg. Two Year Performance

(13%) Avg. Purchase Return
(6%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(3%)(9%)(12%)(21%)(13%)
Purchase Success Rate3 of 63 of 62 of 61 of 61 of 6
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 30 of 30 of 30 of 30 of 3

PDL BioPharma Inc.

Drugs » Biotechnology

Vice President, CFO:

Holdings: 225.03K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Adhera Therapeutics, Inc.

Drugs » Biotechnology

Chief Financial Officer:

Holdings: 5.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

BioTime Inc.

Drugs » Biotechnology

Chief Financial Officer:

Holdings: 7.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Alx Oncology Holdings Inc

Other » Other

Chief Financial Officer:

Holdings: 110.35K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Durect Corp.

Drugs » Drug Manufacturers - Other

Director:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--